Literature DB >> 9376674

Carbohydrates and antigen recognition by T cells.

F R Carbone1, P A Gleeson.   

Abstract

T Lymphocytes (T cells) recognize short antigenic peptides bound to either MHC I or II molecules, in contrast to antibodies which can bind to native antigen. The mechanism by which antigens are processed into peptides, and the nature of the interactions of antigenic peptides with MHC molecules and with the T cell receptor have now been defined in some detail. Of significance to glycobiologists is the recent appreciation that the carbohydrate of glycoprotein antigens can contribute to the T cell recognition of epitopes presented by MHC molecules. Experiments using model T cell epitopes have demonstrated that carbohydrate can modulate T cell responses in a variety of ways; for example, there are a number of cases where glycopeptide-specific T cell responses have been identified. Many of these glycopeptide-specific T cell responses involve a peptide bearing a single glycosyl residue, thus it appears very likely that both glycan and peptide make contact with the T cell receptor binding site. Significantly, glycopeptide-specific T cell responses have also been detected to native glycoproteins. The ability of carbohydrate to influence T cell recognition of antigen has important consequences for a wide range of immune responses as well as the current strategies for mapping T cell determinants.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9376674     DOI: 10.1093/glycob/7.6.725-d

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  17 in total

Review 1.  Do post-translational beta cell protein modifications trigger type 1 diabetes?

Authors:  Joachim Størling; Anne Julie Overgaard; Caroline Anna Brorsson; Francesco Piva; Claus Heiner Bang-Berthelsen; Claus Haase; Jørn Nerup; Flemming Pociot
Journal:  Diabetologia       Date:  2013-09-19       Impact factor: 10.122

2.  Antibody recognition of a unique tumor-specific glycopeptide antigen.

Authors:  Cory L Brooks; Andrea Schietinger; Svetlana N Borisova; Peter Kufer; Mark Okon; Tomoko Hirama; C Roger Mackenzie; Lai-Xi Wang; Hans Schreiber; Stephen V Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

3.  Deglycosylation of the 45/47-kilodalton antigen complex of Mycobacterium tuberculosis decreases its capacity to elicit in vivo or in vitro cellular immune responses.

Authors:  F Romain; C Horn; P Pescher; A Namane; M Riviere; G Puzo; O Barzu; G Marchal
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

4.  Tn glycosylation of the MUC6 protein modulates its immunogenicity and promotes the induction of Th17-biased T cell responses.

Authors:  Teresa Freire; Richard Lo-Man; Sylvie Bay; Claude Leclerc
Journal:  J Biol Chem       Date:  2010-12-30       Impact factor: 5.157

5.  Identification of a gastritogenic epitope of the H/K ATPase beta-subunit.

Authors:  H D De Silva; P A Gleeson; B H Toh; I R Van Driel; F R Carbone
Journal:  Immunology       Date:  1999-01       Impact factor: 7.397

Review 6.  Biomaterials for Mimicking and Modelling Tumor Microenvironment.

Authors:  Rupambika Das; Javier G Fernandez
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 7.  Bridging innate and adaptive antitumor immunity targeting glycans.

Authors:  Anastas Pashov; Bejatolah Monzavi-Karbassi; Gajendra P S Raghava; Thomas Kieber-Emmons
Journal:  J Biomed Biotechnol       Date:  2010-06-15

8.  The role of Ser-(Arg-Ser-Arg-Ser-GlucNAc)19-GlucNAc Fasciola gigantica glycoprotein in the diagnosis of prepatent fasciolosis in rabbits.

Authors:  Eman H Abdel-Rahman; Azza H Mohamed; Adel A H Abdel-Rahman; Eman E El Shanawany
Journal:  J Parasit Dis       Date:  2014-04-26

Review 9.  Mammalian glycosylation in immunity.

Authors:  Jamey D Marth; Prabhjit K Grewal
Journal:  Nat Rev Immunol       Date:  2008-11       Impact factor: 53.106

Review 10.  Tumor-Associated Glycans and Immune Surveillance.

Authors:  Behjatolah Monzavi-Karbassi; Anastas Pashov; Thomas Kieber-Emmons
Journal:  Vaccines (Basel)       Date:  2013-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.